Risk of short telomere as biomarker of diabetes mellitus type 2 status in the CORDIOPREV study

Ana Ojeda-Rodriguez, Maria Jose Parraga-Viudez, Juan L. Romero-Cabrera, Alejandro López-Moreno, Javier Arenas-Montes, Ana Isabel Pérez Caballero, Raul M. Luque, Javier Delgado-Lista, Oriol Rangel-Zuñiga, Jose Lopez-Miranda

Open source

DOI
10.1016/j.arteri.2025.500888
Published
2026-09
Container
Clínica e Investigación en Arteriosclerosis
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.arteri.2025.500888,
  title = {Risk of short telomere as biomarker of diabetes mellitus type 2 status in the CORDIOPREV study},
  author = {Ana Ojeda-Rodriguez and Maria Jose Parraga-Viudez and Juan L. Romero-Cabrera and Alejandro López-Moreno and Javier Arenas-Montes and Ana Isabel Pérez Caballero and Raul M. Luque and Javier Delgado-Lista and Oriol Rangel-Zuñiga and Jose Lopez-Miranda},
  year = {2026},
  journal = {Clínica e Investigación en Arteriosclerosis},
  doi = {10.1016/j.arteri.2025.500888},
  url = {https://doi.org/10.1016/j.arteri.2025.500888}
}

RIS

TY  - JOUR
TI  - Risk of short telomere as biomarker of diabetes mellitus type 2 status in the CORDIOPREV study
AU  - Ana Ojeda-Rodriguez
AU  - Maria Jose Parraga-Viudez
AU  - Juan L. Romero-Cabrera
AU  - Alejandro López-Moreno
AU  - Javier Arenas-Montes
AU  - Ana Isabel Pérez Caballero
AU  - Raul M. Luque
AU  - Javier Delgado-Lista
AU  - Oriol Rangel-Zuñiga
AU  - Jose Lopez-Miranda
PY  - 2026
JO  - Clínica e Investigación en Arteriosclerosis
DO  - 10.1016/j.arteri.2025.500888
UR  - https://doi.org/10.1016/j.arteri.2025.500888
ER  - 

APA

Ojeda-Rodriguez, A., Parraga-Viudez, M. J., Romero-Cabrera, J. L., López-Moreno, A., Arenas-Montes, J., Caballero, A. I. P., Luque, R. M., Delgado-Lista, J., Rangel-Zuñiga, O., & Lopez-Miranda, J. (2026). Risk of short telomere as biomarker of diabetes mellitus type 2 status in the CORDIOPREV study. Clínica e Investigación en Arteriosclerosis. https://doi.org/10.1016/j.arteri.2025.500888

Source records